NAS: DCPH
After Hours
--Quotes are delayed by 20 min
May 16, 2022, 5:51 p.m.
$
10.50
Change
-0.12 -1.13%
Volume
Volume 87,013
Quotes are delayed by 20 min
Today's close
$ 10.31
$ 10.62
Change
+0.31 +3.01%
Day low
Day high
$10.10
$10.86
52 week low
52 week high
$6.51
$38.91
Mr. Steven L. Hoerter President & Chief Executive Officer |
Mr. Thomas P. Kelly Chief Financial Officer, Treasurer & Executive VP |
Dr. Matthew L. Sherman Chief Medical Officer & Executive Vice President |
Dr. Rodrigo Ruiz Soto Senior Vice President-Clinical Development |
Dr. Daniel L. Flynn Chief Scientific Officer & Executive VP |
Dr. Stephen B. Ruddy Chief Technical Officer & SVP |
Mr. Daniel C. Martin Chief Commercial Officer & SVP |
Mr. Jeffrey M. Held General Counsel & Senior Vice President |
Mr. Jama Pitman Vice President-Regulatory & Quality Assurance |
Dr. James A. Bristol Chairman |
Dr. Susan L. Kelley Independent Director |
Mr. Ron Squarer Independent Director |
Mr. Franklin S. Friedman Independent Director |
Ms. Patricia L. Allen Independent Director |
Dr. Edward J. Benz Independent Director |
Mr. John R. Martin Independent Director |
Mr. Dennis L. Walsh Independent Director |
What is a high-deductible Medigap plan, and is it worth the cost?
Berkshire Hathaway Sold Nearly All Its Verizon Stake in the First Quarter, Bought Citigroup
Hundreds of Ukrainian fighters, including wounded, evacuated from Mariupol steel mill
Biden administration expands flights to Cuba, lifts remittance limits
Free rapid at-home COVID tests: You can order a third round from the federal government — here’s how
FEC deadlocks, won’t punish Trump over questionable 2020 campaign spending
Rivian warns price dispute with seat supplier could impact Amazon van order
A smart way to play Tesla’s big stock-market swings using options
FDA authorizes Labcorp's direct-to-consumer test for RSV, the flu, and COVID-19
Customers at Many Crypto Platforms Could Lose Funds in a Bankruptcy
Court’s redistricting plan for New York would be more Republican-friendly
Abbott, FDA reach deal to resume making baby formula at U.S. plant amid shortage
Virtual Stock Exchange